The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $66.07

Today's change+1.82 +2.83%
Updated April 24 4:01 PM EDT. Delayed by at least 15 minutes.
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $66.07

Today's change+1.82 +2.83%
Updated April 24 4:01 PM EDT. Delayed by at least 15 minutes.

AbbVie Inc Hits New 50-day High

AbbVie Inc closed up sharply Friday, rallying (U.S.)$1.82 or 2.83% to (U.S.)$66.07 and setting a new 50-day high. Over the last five days, shares have gained 6.07%, but are currently unchanged over the last year to date. Shares have outperformed the S&P 500 by 21.73% during the last year.

Key company metrics

  • Open(U.S.) $64.31
  • Previous close(U.S.) $64.25
  • High(U.S.) $66.37
  • Low(U.S.) $64.14
  • Bid / Ask-- / --
  • YTD % change+0.96%
  • Volume14,859,514
  • Average volume (10-day)12,410,336
  • Average volume (1-month)11,699,679
  • Average volume (3-month)12,855,020
  • 52-week range(U.S.) $48.95 to (U.S.) $70.76
  • Beta--
  • Trailing P/E58.74×
  • P/E 1 year forward13.63×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.04
  • Dividend yield3.09%
  • Trailing EPS(U.S.) $1.12
Updated April 24 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.89%

Based on its net profit margin of 8.89%, AbbVie Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue5,4525,0194,9264,563
Total other revenue--------
Total revenue5,4525,0194,9264,563
Gross profit4,3333,9553,8373,475
Total cost of revenue1,1191,0641,0891,088
Total operating expense5,8674,0593,4113,212
Selling / general / administrative3,3411,5951,4481,340
Research & development879812834772
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)2831516--
Other operating expenses, total500250----
Operating income-4159601,5151,351
Interest income (expense), net non-operating-139-148-73-70
Gain (loss) on sale of assets--------
Other--------
Income before tax-1,0376871,4331,286
Income after tax-8105061,098980
Income tax, total-227181335306
Net income-8105061,098980
Total adjustments to net income--------
Net income before extra. items-8105061,098980
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-8105061,098980
Inc. avail. to common incl. extra. items-8105061,098980
Diluted net income-8105061,098980
Dilution adjustment00----
Diluted weighted average shares1,5951,6101,6081,609
Diluted EPS excluding extraordinary itemsvalue per share-0.510.310.680.61
Dividends per sharevalue per share0.420.420.420.40
Diluted normalized EPSvalue per share-0.490.510.690.61